🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs
4,713

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Page 32 of 99

  1. CPI-818

    Corvus Pharmaceuticals

    T-cell Lymphoma

    phase 1 small molecule active

    1 trial

  2. CPP-115

    CATALYST PHARMACEUTICALS, INC.

    Cocaine Dependency

    phase 1 small molecule completed

    1 trial

  3. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Acute Myelogenous Leukemia

    phase 1 small molecule completed

    1 trial

  4. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Myelodysplastic Syndromes

    phase 1 small molecule active

    2 trials

  5. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Hematologic Malignancy

    phase 1 small molecule completed

    1 trial

  6. CPX-351 (Cytarabine:Daunorubicin) Liposome Injection

    Jazz Pharmaceuticals Ireland Limited

    Hematologic Neoplasms

    phase 1 small molecule completed

    1 trial

  7. CRB-913

    Corbus Pharmaceuticals Holdings

    Obese But Otherwise Healthy Participants

    phase 1 small molecule active

    1 trial

  8. CRB4101

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Adult Subjects

    phase 1 small molecule active

    1 trial

  9. CRD-TMH-001

    Ultragenyx UK Limited

    Duchenne Muscular Dystrophy

    phase 1 small molecule active

    1 trial

  10. CRN00808

    Crinetics Pharmaceuticals Europe GmbH

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. CRN01941 Oral Solution

    Crinetics Pharmaceuticals Europe GmbH

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  12. CRN04894 Oral Solution

    Crinetics Pharmaceuticals Europe GmbH

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  13. CRV431

    Hepion Pharmaceuticals

    Hepatitis B

    phase 1 small molecule completed

    1 trial

  14. CS-101

    The First People's Hospital of Lianyungang

    Beta-Thalassemia

    phase 1 mab completed

    1 trial

  15. CS-1103

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorders

    phase 1 small molecule completed

    1 trial

  16. CSL760

    CSL Behring GmbH

    Coronavirus Disease 2019 (COVID-19)

    phase 1 mab terminated

    1 trial

  17. CT-0508

    Carisma Therapeutics

    HER2-positive

    phase 1 mab active

    1 trial

  18. CT-0525

    Carisma Therapeutics

    HER2-positive

    phase 1 small molecule active

    1 trial

  19. CT-202

    Context Therapeutics

    Triple Negative Breast Cancer (TNBC)

    phase 1 small molecule active

    1 trial

  20. CT-95

    Context Therapeutics

    Mesothelin-Expressing Tumors

    phase 1 small molecule active

    1 trial

  21. CT-996

    The First People's Hospital of Lianyungang

    Type 2 Diabetes

    phase 1 small molecule completed

    1 trial

  22. CT-G11

    Celltrion Healthcare Australia Pty Ltd

    Healthy

    phase 1 small molecule completed

    1 trial

  23. CT-P41

    Celltrion Healthcare Australia Pty Ltd

    Healthy Male Subjects

    phase 1 mab completed

    1 trial

  24. CT-P6 SC

    Celltrion Healthcare Australia Pty Ltd

    Healthy

    phase 1 mab completed

    1 trial

  25. CT053PTSA

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  26. CT053PTSA

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acute Myeloid Leukemia (AML)

    phase 1 small molecule terminated

    1 trial

  27. CT1812

    COGNITION THERAPEUTICS INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  28. CT1812

    COGNITION THERAPEUTICS INC

    Cognitive Impairment

    phase 1 small molecule completed

    1 trial

  29. CTA101

    The First People's Hospital of Lianyungang

    Diffuse Large B-cell Lymphoma

    phase 1 mab active

    1 trial

  30. CTIM-76

    Context Therapeutics

    Platinum-resistant Ovarian Cancer

    phase 1 small molecule active

    1 trial

  31. CTX-10726

    Compass Therapeutics

    Gastroesophageal Cancer (GC)

    phase 1 small molecule active

    1 trial

  32. CTX-471

    Compass Therapeutics

    Locally Advanced Solid Tumor

    phase 1 small molecule completed

    1 trial

  33. CTX-8371

    Compass Therapeutics

    Non Small Cell Lung Cancer

    phase 1 small molecule active

    1 trial

  34. CTX112

    S.A.

    SLE (Systemic Lupus)

    phase 1 mab active

    1 trial

  35. CTX120

    S.A.

    Multiple Myeloma

    phase 1 mab terminated

    1 trial

  36. CTX130

    S.A.

    Renal Cell Carcinoma

    phase 1 mab terminated

    1 trial

  37. CTX130

    S.A.

    T Cell Lymphoma

    phase 1 mab terminated

    1 trial

  38. CTX310

    S.A.

    Cardiovascular

    phase 1 small molecule active

    1 trial

  39. CUE-101

    Cue Biopharma

    Head and Neck Cancer

    phase 1 small molecule completed

    1 trial

  40. CUE-102

    Cue Biopharma

    Recurrent Glioblastoma

    phase 1 mab active

    1 trial

  41. CUE-102

    Cue Biopharma

    Colorectal Cancer

    phase 1 small molecule completed

    1 trial

  42. CVA

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 1 small molecule active

    1 trial

  43. CVL-354

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  44. CVL-354

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 1 small molecule completed

    1 trial

  45. CX-188

    CytomX Therapeutics

    Solid Tumor, Adult

    phase 1 small molecule terminated

    1 trial

  46. CX-2051

    CytomX Therapeutics

    Solid Tumor, Adult

    phase 1 small molecule active

    1 trial

  47. CX-801

    CytomX Therapeutics

    Solid Tumor, Adult

    phase 1 small molecule active

    1 trial

  48. CX-904

    CytomX Therapeutics

    Solid Tumors

    phase 1 small molecule terminated

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.